Gene Symbol | Pearson Correlation Coefficient |
---|---|
NGEF | 0.974 |
PGBD5 | 0.967 |
SLC8A2 | 0.962 |
PRKCG | 0.956 |
CAMKK2 | 0.955 |
KCNB1 | 0.954 |
C1orf115 | 0.953 |
KCTD1 | 0.953 |
RAB3A | 0.951 |
KIAA0513 | 0.951 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
TFPI2 | -0.583 |
WWTR1 | -0.579 |
MYL3 | -0.566 |
YES1 | -0.559 |
SNHG18 | -0.551 |
REST | -0.549 |
HEY2 | -0.541 |
CNN2 | -0.539 |
RAI14 | -0.534 |
KIAA0040 | -0.527 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased methylation of CACNG3 gene | 27153756 |
D000535 | Aluminum | [APP protein modified form binds to Aluminum] which results in decreased expression of CACNG3 mRNA | 21298039 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of CACNG3 mRNA | 16483693 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CACNG3 mRNA | 20458559 |
D001464 | Barium | CACNG3 protein affects the transport of Barium | 11313431 |
C006780 | bisphenol A | bisphenol A affects the expression of CACNG3 mRNA | 25181051 |
D002211 | Capsaicin | Capsaicin results in decreased expression of CACNG3 mRNA | 16278290 |
D002509 | Cephaloridine | Cephaloridine results in increased expression of CACNG3 mRNA | 18500788 |
D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of CACNG3 mRNA | 21266533 |
D019813 | 1,2-Dimethylhydrazine | "[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of CACNG3 mRNA" | 27840820 |
D005419 | Flavonoids | Flavonoids results in decreased expression of CACNG3 mRNA | 18035473 |
D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CACNG3 mRNA" | 20188158 |
C410127 | PCB 180 | PCB 180 results in decreased expression of CACNG3 mRNA | 23829299 |
C025462 | sulindac sulfide | sulindac sulfide results in increased expression of CACNG3 mRNA | 16184548 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of CACNG3 mRNA | 24680724 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of CACNG3 mRNA | 24896083 |
D001335 | Vehicle Emissions | Vehicle Emissions results in decreased methylation of CACNG3 gene | 25560391 |
C025643 | vinclozolin | vinclozolin affects the expression of CACNG3 mRNA | 19015723 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005245 | voltage-gated calcium channel activity | - | IBA | 21873635 |
GO:0005245 | voltage-gated calcium channel activity | - | NAS | 10221464 |
GO:0016247 | channel regulator activity | - | IBA | 21873635 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0006605 | protein targeting | - | ISS | - |
GO:0006816 | calcium ion transport | - | NAS | 10221464 |
GO:0008104 | protein localization | - | ISS | - |
GO:0019226 | transmission of nerve impulse | - | IBA | 21873635 |
GO:0051968 | positive regulation of synaptic transmission, glutamatergic | - | IBA | 21873635 |
GO:0098943 | neurotransmitter receptor transport, postsynaptic endosome to lysosome | - | IBA | 21873635 |
GO:0098970 | postsynaptic neurotransmitter receptor diffusion trapping | - | IBA | 21873635 |
GO:0099590 | neurotransmitter receptor internalization | - | IBA | 21873635 |
GO:2000311 | regulation of AMPA receptor activity | - | IBA | 21873635 |
GO:2000311 | regulation of AMPA receptor activity | - | ISS | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005886 | plasma membrane | - | TAS | - |
GO:0005891 | voltage-gated calcium channel complex | - | NAS | 10221464 |
GO:0030666 | endocytic vesicle membrane | - | TAS | - |
GO:0032281 | AMPA glutamate receptor complex | - | IBA | 21873635 |
GO:0032281 | AMPA glutamate receptor complex | - | ISS | - |
GO:0036477 | somatodendritic compartment | - | ISS | - |
GO:0098839 | postsynaptic density membrane | - | IBA | 21873635 |
KEGG ID | KEGG Term |
---|---|
hsa04010 | MAPK signaling pathway |
hsa04260 | Cardiac muscle contraction |
hsa05410 | Hypertrophic cardiomyopathy (HCM) |
hsa05412 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) |
hsa05414 | Dilated cardiomyopathy |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | TAS |
R-HSA-112315 | Transmission across Chemical Synapses | TAS |
R-HSA-112316 | Neuronal System | TAS |
R-HSA-1266738 | Developmental Biology | TAS |
R-HSA-397014 | Muscle contraction | TAS |
R-HSA-399719 | Trafficking of AMPA receptors | TAS |
R-HSA-399721 | Glutamate binding, activation of AMPA receptors and synaptic plasticity | TAS |
R-HSA-5576891 | Cardiac conduction | TAS |
R-HSA-5576892 | Phase 0 - rapid depolarisation | TAS |
R-HSA-5576893 | Phase 2 - plateau phase | TAS |
R-HSA-5682910 | LGI-ADAM interactions | TAS |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
21169531 | Dissection of chromosome 16p12 linkage peak suggests a possible role for CACNG3 variants in age-related macular degeneration susceptibility. (2011 Mar) | Spencer KL | Invest Ophthalmol Vis Sci |